支架植入治疗恶性肿瘤所致上腔静脉综合征的临床价值

摘要

Objective To explore the clinical value of superior vena cava syndrome (SVCS) caused by malignant tumor with stent implantation treatment. Methods 36 patients with SVCS caused by malignant tumor clearly diagnosed during cubits vein angiography, transantecubital vein or femoral vein approach, with balloon dilation on narrow, then implanted stent in superior vena cava and brachiocephalic vein tight quarter. Results 38 stents were successfully implanted in 36 patients, stents in 2 patients were obstructed after operation, and opened again after respective implantation of one stent. Stents in the other patients kept unobstructed in their lifetime. Conclusion Stent implantation treatment is a method of rapidly effective, less complications for SVCS caused by malignant tumor and has a higher value of clinical application.%目的 探讨支架植入治疗恶性肿瘤导致上腔静脉综合征的临床价值.方法 恶性肿瘤导致上腔静脉阻塞患者36例,经患侧肘静脉造影明确诊断,经肘前静脉或股静脉入路,先行狭窄部位球囊扩张术,然后在上腔静脉和头臂静脉狭窄段植入支架.结果 36例患者成功植入支架38枚,2例术后支架再次闭塞,分别再次植入支架1枚后血管再次开通,其余病例在生存期内支架保持通畅.结论 支架植入治疗恶性肿瘤导致上腔静脉综合征症状缓解迅速有效、并发症较少,有较高的临床应用价值.